chartexchange

URGN
UroGen Pharma Ltd.
stockNASDAQ

Market OpenNov 19, 2026 9:42:19 AM EST
30.50USD+2.383%(+0.71)38,248
Pre-marketNov 19, 2026 8:31:30 AM EST
31.11USD+4.431%(+1.32)
30.16Bid34.91Ask4.75Spread

URGN Financials

In Q3 FY 2026 (ended ), UroGen Pharma Ltd. (URGN) reported revenue of $89M, net income of −$1.46M, operating cash flow of −$15.2M, and assets of $271.87M (filed ).

Loading financial flows…